Clinical Study
Increased Serum PAI-1 Levels in Subjects with Metabolic Syndrome and Long-Term Adverse Mental Symptoms: A Population-Based Study
Table 2
Odds ratios (OR) with 95% confidence intervals for the risk of the long-term mental symptoms and metabolic syndrome (LMS + MetS) in men and women.
| | Men | Women |
| | OR | 95% CI | P-value | OR | 95% CI | P-value |
| | PAI-1 > median | 3.40 | 1.23–9.40 | .018 | 1.018 | 0.339–3.05 | .975 | | Smoking | 9.93 | 2.56–38.57 | .001 | 7.86 | 1.55–39.73 | .013 | | Overweight | 3.85 | 1.04–14.21 | .043 | 27.36 | 3.17–235.77 | .003 | | Cardiovascular disease | 1.72 | 0.17–17.57 | .646 | 1.82 | 0.33–10.04 | .492 | | Age | 1.02 | 0.97–1.07 | .373 | 0.97 | 0.91–1.04 | .408 | | Marital status (single) | 2.57 | 0.69–9.59 | .160 | 5.22 | 1.16–23.55 | .032 | | Alcohol more than 2 × week | 1.07 | 0.37–3.08 | .904 | 0.65 | 0.12–3.53 | .617 |
|
|
